Skip to menu Skip to content Skip to footer

2007

Journal Article

Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents

Ramachandran, Manoj, Ward, Kate, Brown, Richard R., Munns, Craig F., Cowell, Christopher T. and Little, David G. (2007). Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents. Journal of Bone and Joint Surgery - Series A, 89 (8), 1727-1734. doi: 10.2106/JBJS.F.00964

Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents

2006

Journal Article

Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatment

Land, Christof, Rauch, Frank, Munns, Craig F., Sahebjam, Solmaz and Glorieux, Francis H. (2006). Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatment. Bone, 39 (4), 901-906. doi: 10.1016/j.bone.2006.04.004

Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatment

2006

Journal Article

Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: A consensus statement

Munns, Craig, Zacharin, Margaret R., Rodda, Christine P., Batch, Jennifer A., Morley, Ruth, Cranswick, Noel E., Craig, Maria E., Cutfield, Wayne S., Hofman, Paul L., Taylor, Barry J., Grover, Sonia R., Pasco, Julie A., Burgner, David and Cowell, Christopher T. (2006). Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: A consensus statement. Medical Journal of Australia, 185 (5), 268-272. doi: 10.5694/j.1326-5377.2006.tb00558.x

Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: A consensus statement

2006

Journal Article

Pamidronate in children and adolescents with osteogenesis imperfecta: Effect of treatment discontinuation

Rauch, Frank, Munns, Craig, Land, Christof and Glorieux, Francis H. (2006). Pamidronate in children and adolescents with osteogenesis imperfecta: Effect of treatment discontinuation. Journal of Clinical Endocrinology and Metabolism, 91 (4), 1268-1274. doi: 10.1210/jc.2005-2413

Pamidronate in children and adolescents with osteogenesis imperfecta: Effect of treatment discontinuation

2006

Journal Article

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V

Zeitlin, Leonid, Rauch, Frank, Travers, Rose, Munns, Craig and Glorieux, Francis H. (2006). The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V. Bone, 38 (1), 13-20. doi: 10.1016/j.bone.2005.07.020

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V

2005

Journal Article

Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: Clinical and histomorphometric outcome

Munns, Craig F.J., Rauch, Frank, Travers, Rose and Glorieux, Francis H. (2005). Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: Clinical and histomorphometric outcome. Journal of Bone and Mineral Research, 20 (7), 1235-1243. doi: 10.1359/JBMR.050213

Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: Clinical and histomorphometric outcome

2005

Journal Article

Prevention and treatment of osteoporosis in chronically ill children

Munns, Craig F.J. and Cowell, C. T. (2005). Prevention and treatment of osteoporosis in chronically ill children. Journal of Musculoskeletal Neuronal Interactions, 5 (3), 262-272.

Prevention and treatment of osteoporosis in chronically ill children

2004

Journal Article

Three children with lower limb fractures and a mineralization defect: A novel bone fragility disorder?

Munns, Craig F.J., Rauch, Frank, Travers, Rose and Glorieux, Francis H. (2004). Three children with lower limb fractures and a mineralization defect: A novel bone fragility disorder?. Bone, 35 (5), 1023-1028. doi: 10.1016/j.bone.2004.08.004

Three children with lower limb fractures and a mineralization defect: A novel bone fragility disorder?

2004

Journal Article

Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate

Munns, Craig F.J., Rauch, Frank, Zeitlin, Leonid, Fassier, François and Glorieux, Francis H. (2004). Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. Journal of Bone and Mineral Research, 19 (11), 1779-1786. doi: 10.1359/JBMR.040814

Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate

2004

Journal Article

Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases

Munns, Craig F.J., Rauch, Frank, Ward, Leanne and Glorieux, Francis H. (2004). Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases. Journal of Bone and Mineral Research, 19 (10), 1742-1745. doi: 10.1359/JBMR.040711

Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases

2004

Journal Article

Clinical vignette - Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysis

Rauch, Frank, Travers, Rose, Munns, Craig and Glorieux, Francis H. (2004). Clinical vignette - Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysis. Journal of Bone and Mineral Research, 19 (7), 1191-1193. doi: 10.1359/JBMR.040303

Clinical vignette - Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysis

2004

Journal Article

Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta

Munns, Craig F., Rauch, Frank, Mier, Richard J. and Glorieux, Francis H. (2004). Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone, 35 (1), 231-234. doi: 10.1016/j.bone.2004.03.008

Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta

2003

Journal Article

Familial growth and skeletal features associated with SHOX haploinsufficiency

Munns, C. F. J., Glass, I. A., Flanagan, S., Hayes, M., Williams, B., Berry, M., Vickers, D., O'Rourke, P., Rao, E., Rappold, G. A., Hyland, V. J. and Batch, J. A. (2003). Familial growth and skeletal features associated with SHOX haploinsufficiency. Journal of Pediatric Endocrinology and Metabolism, 16 (7), 987-996. doi: 10.1515/JPEM.2003.16.7.987

Familial growth and skeletal features associated with SHOX haploinsufficiency

2003

Journal Article

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

Plotkin, Horacio, Rauch, Frank, Zeitlin, Leonid, Munns, Craig, Travers, Rose and Glorieux, Francis H. (2003). Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone. Journal of Clinical Endocrinology and Metabolism, 88 (10), 4569-4575. doi: 10.1210/jc.2003-030050

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

2003

Journal Article

Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency

Munns, C. F. J., Berry, M., Vickers, D., Rappold, G. A., Hyland, V. J., Glass, I. A. and Batch, J. A. (2003). Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency. Journal of Pediatric Endocrinology and Metabolism, 16 (7), 997-1004. doi: 10.1515/JPEM.2003.16.7.997

Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency

2002

Journal Article

Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood [4]

Flanagan, S. F., Munns, C. F.J., Hayes, M., Williams, B., Berry, M., Vickers, D., Rao, E., Rappold, G. A., Batch, J. A., Hyland, V. J. and Glass, I. A. (2002). Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood [4]. Journal of Medical Genetics, 39 (10), 758-763.

Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood [4]

2001

Journal Article

Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes

Healey, S. C., Kirk, K. M., Hyland, V. J., Munns, C., Henders, A. K., Batch, J. A., Heath, A. C., Martin, N. G. and Glass, I. A. (2001). Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes. Twin Research, 4 (1), 19-24. doi: 10.1375/twin.4.1.19

Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes

2000

Journal Article

Hepatic glycogenosis: Reversible hepatomegaly in type 1 diabetes

Munns, C. F. J., McCrossin, R. B., Thomsett, M. J. and Batch, J. (2000). Hepatic glycogenosis: Reversible hepatomegaly in type 1 diabetes. Journal of Paediatrics and Child Health, 36 (5), 449-452. doi: 10.1046/j.1440-1754.2000.00547.x

Hepatic glycogenosis: Reversible hepatomegaly in type 1 diabetes